Stoke Therapeutics CMO Stock Sale Sparks Investor Debate
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
New crypto investors should know key insights to thrive in the market. Equip yourself with the right information for success.
28,386 articlesA biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
OpenAI teams with Broadcom to introduce its first custom AI accelerator, Jalapeño. The move signals a broader strateg...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...
A rising AI startup is inviting accredited investors to join a pre-IPO round at $0.85 per share before a March 12 dea...
SpaceX (SPCX) has fallen about 30% from its peak while planning a large debt raise. This guide breaks down what the d...
Tesla's latest moves in robotaxi expansion and a tease of a big announcement sparked a rally. Learn what drove the ju...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
CoreWeave faced a sharp move after its latest earnings, with shares slipping in after-hours trading despite a top-lin...
Investors just got a fresh catalyst as Uber commits to autonomous progress. This article breaks down what Dara Khosro...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...